Substance: brivaracetam
Commercial code: W71193001
Concentration: 75mg
Pharmaceutical form: tablets
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
N03AX23 • brivaracetam • Nervous system | Antiepileptics | Other antiepileptics
Brivaracetamum is a medication used for the treatment of epilepsy, specifically focal seizures with or without secondary generalization, in patients aged 4 years and older. It is an antiepileptic drug that works by binding to the synaptic vesicle protein SV2A, reducing neuronal excitability.
The medication is administered orally or intravenously, as directed by a doctor. The dosage is adjusted based on the patient's age, weight, and response to treatment.
Common side effects include drowsiness, dizziness, fatigue, and irritability. In rare cases, more severe adverse effects such as depression or suicidal thoughts may occur, requiring close monitoring of patients.
Brivaracetamum is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
Substance: brivaracetam
Commercial code: W71193001
Concentration: 75mg
Pharmaceutical form: tablets
Product type: generic
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: ACTAVIS LTD. - MALTA
Holder: TEVA B.V. - TARILE DE JOS
Number: 16081/2025/01
Shelf life: 2 years